Similar to anti-IFN-α antibodies, these TLR-7 and -9 antagonists are now being considered for the treatment of SLE [68], and upcoming clinical trials may provide important information on their applicability to HIV infection. The gene discussed is IFNA2; the disease is systemic lupus erythematosus.